Sensei Biotherapeutics, Inc.盘中异动临近收盘快速上涨8.04%

市场透视2025-02-25

北京时间2025年02月25日04时30分，Sensei Biotherapeutics, Inc.（SNSE.us）股票出现异动，股价急速上涨8.04%。截至发稿，该股报0.487美元/股，成交量14.5618万股，换手率0.58%，振幅10.26%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-7.25百万美元，每股收益-0.29美元，毛利-140000.00美元，市盈率-0.41...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2514703751?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-25 04:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2514703751","market":"us","top_or_hot":-1,"title":"Sensei Biotherapeutics, Inc.盘中异动 临近收盘快速上涨8.04%","media":"市场透视","content":"<div>\n<p>北京时间2025年02月25日04时30分，Sensei Biotherapeutics, Inc.（SNSE.us）股票出现异动，股价急速上涨8.04%。截至发稿，该股报0.487美元/股，成交量14.5618万股，换手率0.58%，振幅10.26%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-7.25百万美元，每股收益-0.29美元，毛利-140000.00美元，市盈率-0.41...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225043046a2525f8c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sensei Biotherapeutics, Inc.盘中异动 临近收盘快速上涨8.04%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSensei Biotherapeutics, Inc.盘中异动 临近收盘快速上涨8.04%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-25 04:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225043046a2525f8c&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年02月25日04时30分，Sensei Biotherapeutics, Inc.（SNSE.us）股票出现异动，股价急速上涨8.04%。截至发稿，该股报0.487美元/股，成交量14.5618万股，换手率0.58%，振幅10.26%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-7.25百万美元，每股收益-0.29美元，毛利-140000.00美元，市盈率-0.41...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225043046a2525f8c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225043046a2525f8c&s=b","article_id":"2514703751","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225043046a2525f8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2514703751","pubTimestamp":1740429045,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年02月25日04时30分，Sensei Biotherapeutics, Inc.股票出现异动，股价急速上涨8.04%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为327.66%、143.45%、41.21%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、162.04%、81.92%。Sensei Biotherapeutics, Inc.公司简介：Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司，致力于发现和开发治疗癌症患者的新一代疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","SNSE":"Sensei Biotherapeutics, Inc."},"translate_title":"Sensei Biotherapeutics, Inc. Intraday Movement Quickly Rises 8.04% Near Close","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNSE":1},"content_text":"北京时间2025年02月25日04时30分，Sensei Biotherapeutics, Inc.（SNSE.us）股票出现异动，股价急速上涨8.04%。截至发稿，该股报0.487美元/股，成交量14.5618万股，换手率0.58%，振幅10.26%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-7.25百万美元，每股收益-0.29美元，毛利-140000.00美元，市盈率-0.41倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Nutriband Inc C/Wts (To Pur Com)、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 (To Pur Com)涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为327.66%、143.45%、41.21%，振幅较大的相关个股有Nutriband Inc C/Wts (To Pur Com)、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 (To Pur Com)，振幅分别为176.22%、162.04%、81.92%。Sensei Biotherapeutics, Inc.公司简介：Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司，致力于发现和开发治疗癌症患者的新一代疗法。该公司的 TMAb（肿瘤微环境激活生物制剂）平台开发高度选择性的治疗药物，旨在使肿瘤微环境中的免疫抑制信号失效或有选择地激活免疫刺激信号。公司有四种处于不同开发阶段的候选研究产品： SNS-101，SNS-102，SNS-103 和 SNS-20。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2514703751","isCrawlerRequest":true}

Sensei Biotherapeutics, Inc.盘中异动 临近收盘快速上涨8.04%

精彩评论

Sensei Biotherapeutics, Inc.盘中异动临近收盘快速上涨8.04%